Ostium Secundum Atrial Septal Defects Medication

1. Gessner IH. Atrial septal defect. Surgery of Congenital Heart Disease: Pediatric Care Consortium 1984-1995. Armonk, NY: Futura Publishing Co.; 1998. 31-44.

2. Vick GW, Titus JL. Defects of the atrial septum, including the atrioventricular canal. Garson A, Bricker JT, Fisher, DJ, Neish, SR eds. The Science and Practice of Pediatric Cardiology. Baltimore, MD: Lippincott Williams & Wilkins; 1998. Vol 2:

3. Azhari N, Shihata MS, Al-Fatani A. Spontaneous closure of atrial septal defects within the oval fossa. Cardiol Young. 2004 Apr. 14(2):148-55. [QxMD MEDLINE Link].

4. Saxena A, Divekar A, Soni NR. Natural history of secundum atrial septal defect revisited in the era of transcatheter closure. Indian Heart J. 2005 Jan-Feb. 57(1):35-8. [QxMD MEDLINE Link].

5. Hanslik A, Pospisil U, Salzer-Muhar U, Greber-Platzer S, Male C. Predictors of spontaneous closure of isolated secundum atrial septal defect in children: a longitudinal study. Pediatrics. 2006 Oct. 118(4):1560-5. [QxMD MEDLINE Link]. [Full Text].

6. McMahon CJ, Feltes TF, Fraley JK, et al. Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart. 2002 Mar. 87(3):256-9. [QxMD MEDLINE Link].

7. Scheuerle A. Clinical differentiation of patent foramen ovale and secundum atrial septal defect: a survey of pediatric cardiologists in Dallas, Texas, USA. J Registry Manag. 2011 Spring. 38(1):4-8. [QxMD MEDLINE Link].

8. Sachweh JS, Daebritz SH, Hermanns B, et al. Hypertensive pulmonary vascular disease in adults with secundum or sinus venosus atrial septal defect. Ann Thorac Surg. 2006 Jan. 81(1):207-13. [QxMD MEDLINE Link].

9. Siddiqui WT, Parveen S, Siddiqui MT, Amanullah MM. Clinical outcomes of surgically corrected atrial septal defects. J Pak Med Assoc. 2013 May. 63(5):662-5. [QxMD MEDLINE Link].

10. Brochu MC, Baril JF, Dore A, et al. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation. 2002 Oct 1. 106(14):1821-6. [QxMD MEDLINE Link]. [Full Text].

11. Caputo S, Capozzi G, Russo MG, et al. Familial recurrence of congenital heart disease in patients with ostium secundum atrial septal defect. Eur Heart J. 2005 Oct. 26(20):2179-84. [QxMD MEDLINE Link].

12. Sznajer Y, Keren B, Baumann C, et al. The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene. Pediatrics. 2007 Jun. 119(6):e1325-31. [QxMD MEDLINE Link]. [Full Text].

13. Godwin KA, Sibbald B, Bedard T, Kuzeljevic B, Lowry RB, Arbour L. Changes in frequencies of select congenital anomalies since the onset of folic acid fortification in a Canadian birth defect registry. Can J Public Health. 2008 Jul-Aug. 99(4):271-5. [QxMD MEDLINE Link].

14. Arrington CB, Tani LY, Minich LL, Bradley DJ. An assessment of the electrocardiogram as a screening test for large atrial septal defects in children. J Electrocardiol. 2007 Nov-Dec. 40(6):484-8. [QxMD MEDLINE Link].

15. Wu ET, Akagi T, Taniguchi M, et al. Differences in right and left ventricular remodeling after transcatheter closure of atrial septal defect among adults. Catheter Cardiovasc Interv. 2007 May 1. 69(6):866-71. [QxMD MEDLINE Link].

16. Walker RE, Moran AM, Gauvreau K, Colan SD. Evidence of adverse ventricular interdependence in patients with atrial septal defects. Am J Cardiol. 2004 Jun 1. 93(11):1374-7, A6. [QxMD MEDLINE Link].

17. Giardini A, Donti A, Formigari R, et al. Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults. J Am Coll Cardiol. 2004 May 19. 43(10):1886-91. [QxMD MEDLINE Link].

18. Rigatelli G, Dell' Avvocata F, Cardaioli P, Giordan M, Vassiliev D, Nghia NT, et al. Five-year Follow-up of Intracardiac Echocardiography-assisted Transcatheter Closure of Complex Ostium Secundum Atrial Septal Defect. Congenit Heart Dis. 2011 Oct 20. [QxMD MEDLINE Link].

19. Brassard M, Fouron JC, van Doesburg NH, Mercier LA, De Guise P. Outcome of children with atrial septal defect considered too small for surgical closure. Am J Cardiol. 1999 Jun 1. 83(11):1552-5. [QxMD MEDLINE Link].

20. Doll N, Walther T, Falk V, et al. Secundum ASD closure using a right lateral minithoracotomy: five-year experience in 122 patients. Ann Thorac Surg. 2003 May. 75(5):1527-30; discussion 1530-1. [QxMD MEDLINE Link].

21. Argenziano M, Oz MC, Kohmoto T, et al. Totally endoscopic atrial septal defect repair with robotic assistance. Circulation. 2003 Sep 9. 108 Suppl 1:II191-4. [QxMD MEDLINE Link]. [Full Text].

22. Atashband A, Lakkis N. First comprehensive analysis of outcomes in adult patients after percutaneous closure of isolated secundum atrial septal defects. Cardiovasc Hematol Agents Med Chem. 2015. 13(1):63-9. [QxMD MEDLINE Link].

23. Shah D, Azhar M, Oakley CM, et al. Natural history of secundum atrial septal defect in adults after medical or surgical treatment: a historical prospective study. Br Heart J. 1994 Mar. 71(3):224-7; discussion 228. [QxMD MEDLINE Link].

24. Bolz D, Lacina T, Buser P, et al. Long-term outcome after surgical closure of atrial septal defect in childhood with extensive assessment including MRI measurement of the ventricles. Pediatr Cardiol. 2005 Sep-Oct. 26(5):614-21. [QxMD MEDLINE Link].

25. Lock JE, Cockerham JT, Keane JF, et al. Transcatheter umbrella closure of congenital heart defects. Circulation. 1987 Mar. 75(3):593-9. [QxMD MEDLINE Link].

26. Jones TK, Latson LA, Zahn E, et al. Results of the U.S. multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects. J Am Coll Cardiol. 2007 Jun 5. 49(22):2215-21. [QxMD MEDLINE Link].

27. Patel A, Lopez K, Banerjee A, Joseph A, Cao QL, Hijazi ZM. Transcatheter closure of atrial septal defects in adults > or =40 years of age: immediate and follow-up results. J Interv Cardiol. 2007 Feb. 20(1):82-8. [QxMD MEDLINE Link].

28. Post MC, Suttorp MJ, Jaarsma W, Plokker HW. Comparison of outcome and complications using different types of devices for percutaneous closure of a secundum atrial septal defect in adults: a single-center experience. Catheter Cardiovasc Interv. 2006 Mar. 67(3):438-43. [QxMD MEDLINE Link].

29. Shimizu S, Kawamura A, Arai T, et al. Intracardiac echocardiography for percutaneous closure of atrial septal defects: initial experiences in Japan. Cardiovasc Interv Ther. 2013 Oct. 28 (4):368-73. [QxMD MEDLINE Link].

30. Stroker E, Van De Bruaene A, De Meester P, Van Deyck K, Gewillig M, Budts W. Transcatheter device closure of atrial septal defects in patients above age 60. Acta Cardiol. 2013 Apr. 68(2):127-32. [QxMD MEDLINE Link].

31. Kazmouz S, Kenny D, Cao QL, Kavinsky CJ, Hijazi ZM. Transcatheter closure of secundum atrial septal defects. J Invasive Cardiol. 2013 May. 25(5):257-64. [QxMD MEDLINE Link].

32. Taniguchi M, Akagi T, Kijima Y, Sano S. Clinical advantage of real-time three-dimensional transesophageal echocardiography for transcatheter closure of multiple atrial septal defects. Int J Cardiovasc Imaging. 2013 Aug. 29(6):1273-80. [QxMD MEDLINE Link].

33. Chen TH, Hsiao YC, Cheng CC, et al. In-hospital and 4-year clinical outcomes following transcatheter versus surgical closure for secundum atrial septal defect in adults: A national cohort propensity score analysis. Medicine (Baltimore). 2015 Sep. 94(38):e1524. [QxMD MEDLINE Link]. [Full Text].

34. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007 Nov 29. 357(22):2262-8. [QxMD MEDLINE Link].

35. Vida VL, Barnoya J, O'Connell M, et al. Surgical versus percutaneous occlusion of ostium secundum atrial septal defects: results and cost-effective considerations in a low-income country. J Am Coll Cardiol. 2006 Jan 17. 47(2):326-31. [QxMD MEDLINE Link].

36. Butera G, Carminati M, Chessa M, et al. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am Heart J. 2006 Jan. 151(1):228-34. [QxMD MEDLINE Link].

37. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv. 2004 Dec. 63(4):496-502. [QxMD MEDLINE Link].

38. AGA Medical Technical Note, January 2006:1-4.

39. McElhinney DB, Quartermain MD, Kenny D, Alboliras E, Amin Z. Relative risk factors for cardiac erosion following transcatheter closure of atrial septal defects: A case-control study. Circulation. 2016 May 3. 133(18):1738-46. [QxMD MEDLINE Link]. [Full Text].

40. Giardini A, Donti A, Specchia S, Formigari R, Oppido G, Picchio FM. Long-term impact of transcatheter atrial septal defect closure in adults on cardiac function and exercise capacity. Int J Cardiol. 2008 Feb 29. 124(2):179-82. [QxMD MEDLINE Link].

41. Rao PS, Harris AD. Recent advances in managing septal defects: atrial septal defects. F1000Res. 2017. 6:2042. [QxMD MEDLINE Link]. [Full Text].

42. Oliveira EC, Moura MAG, Almeida JA, Ribeiro ALP, Nascimento BR. Percutaneous closure of ostium secundum atrial septal defect using left internal jugular vein access in a child with situs inversus and absence of inferior caval vein. Cardiol Young. 2019 Sep 2. 1-3. [QxMD MEDLINE Link].

43. Mahmoud H, Nicolescu AM, Filip C, et al. Complex atrial septal defect closure in children. Rom J Morphol Embryol. 2019. 60(1):49-57. [QxMD MEDLINE Link]. [Full Text].

Ira H Gessner, MD Professor Emeritus, Pediatric Cardiology, University of Florida College of Medicine

Ira H Gessner, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Pediatric Society, Society for Pediatric Research

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Alvin J Chin, MD Emeritus Professor of Pediatrics, University of Pennsylvania School of Medicine

Disclosure: Nothing to disclose.

Syamasundar Rao Patnana, MD Professor of Pediatrics and Medicine, Division of Cardiology, Emeritus Chief of Pediatric Cardiology, University of Texas Medical School at Houston and Children's Memorial Hermann Hospital

Syamasundar Rao Patnana, MD is a member of the following medical societies: American Academy of Pediatrics, American Pediatric Society, American College of Cardiology, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society for Pediatric Research

Disclosure: Nothing to disclose.

Paul M Seib, MD Associate Professor of Pediatrics, University of Arkansas for Medical Sciences; Medical Director, Cardiac Catheterization Laboratory, Co-Medical Director, Cardiovascular Intensive Care Unit, Arkansas Children's Hospital

Paul M Seib, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, Arkansas Medical Society, International Society for Heart and Lung Transplantation, Society for Cardiovascular Angiography and Interventions

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article